Regut 200mg Tablet
By Regut
Rx
10 Tablet in a Strip

Composition
Rifaximin(200mg)

Manufacturer - Lemford Biotech Pvt Ltd
1251, SECTOR-8, FARIDABAD, HARYANA

Expires on or after
January, 2026

liver
When using Regut 200mg Tablet, it is important to exercise caution if you have severe liver disease. Patients with such conditions may require a dose adjustment for this medication. It is advisable to consult your doctor for guidance on the appropriate use of Regut 200mg Tablet to ensure your liver health is taken into consideration.

kidney
Regut 200mg Tablet is considered safe for use in patients with kidney disease. Information indicates that dose adjustment may not be necessary. Consult your doctor for guidance.

alcohol
Consult your doctor when consuming alcohol with Regut 200mg Tablet.

driving
Regut 200mg Tablet typically does not impact your driving ability.

pregnancy
Regut 200mg Tablet may not be safe to use during pregnancy as limited human studies and animal studies suggest potential harm to the developing baby. Your doctor will assess the benefits and risks before prescribing. Please consult your doctor.

breastfeeding
Regut 200mg Tablet is likely safe to use while breastfeeding. The limited human data available indicates that there is no significant risk to the baby.
Habit Forming | No |
Chemical Class | Rifamycin derivatives |
Therapeutic Class | GASTRO INTESTINAL |
Action Class | RNA polymerase inhibitors- Rifamycins |
₹121.5
₹135
10% OFF
Inclusive of all taxes
Content verified by

Dr. Preeti Kumar
MBBS, DGO - Obstetrics and Gynaecology, DNB - Obstetrics and Gynaecology
Last update on 01-Oct-2024